5 Results for "

senexin

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "senexin" in MCE Product Catalog:

9
9 Publications Verification
Cat. No.: HY-15681
CAS No.: 1366002-50-7
Purity:  99.79%
Target:  

CDK

Research Areas:  

Cancer

Senexin A is an inhibitor of CDK8/19 (IC50: 280 nM, CDK8) and an inhibitor downstream of p21 transcription. It only inhibits p21-induced transcription but does not inhibit other biological effects of p21. Senexin A inhibits CMV-GFP induction as well as the p21 stimulatory activity of the consensus NF-κB-dependent promoters .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101800
CAS No.: 1449228-40-3
Purity:  99.09%
Synonyms: SNX2-1-165; BCD-115
Target:  

CDK

Research Areas:  

Cancer

Senexin B (SNX2-1-165; BCD-115) is a potent, highly water-soluble and bioavailable CDK8/19 inhibitor, with Kds of 140 nM for CDK8 and 80 nM for CDK19.
loading...
    loading...
Cat. No.: HY-143889
CAS No.: 2375554-02-0
Purity:  98.82%
Target:  

CDK

Research Areas:  

Cancer

Senexin C is a selective and orally active CDK8/19 inhibitor. Senexin C shows a strong tumor-enrichment pharmacokinetic (PK) profile and tumor-pharmacodynamic (PD) marker responses. Senexin C inhibits the growth of MV4-11 leukemia cells with good tolerability .
loading...
    loading...
Cat. No.: HY-15681A
CAS No.: 1780390-76-2
Target:  

CDK

Research Areas:  

Cancer

Senexin A hydrochloride is an inhibitor of CDK8/19 (IC50: 280 nM, CDK8) and an inhibitor downstream of p21 transcription. It only inhibits p21-induced transcription but does not inhibit other biological effects of p21. Senexin A hydrochloride inhibits CMV-GFP induction as well as the p21 stimulatory activity of the consensus NF-κB-dependent promoters .
loading...
    loading...
Cat. No.: HY-101800R
CAS No.: 1449228-40-3
Synonyms: SNX2-1-165 (Standard); BCD-115 (Standard)
Target:  

Reference Standards CDK

Research Areas:  

Cancer

Senexin B (Standard) (SNX2-1-165 (Standard)) is the analytical standard of Senexin B (HY-101800). This product is intended for research and analytical applications. Senexin B (SNX2-1-165; BCD-115) is a potent, highly water-soluble and bioavailable CDK8/19 inhibitor, with Kds of 140 nM for CDK8 and 80 nM for CDK19.
loading...
    loading...